February: Clinical Trial Co., Ltd. (a limited liability company at the time) was established. Started recruiting healthy volunteers for clinical trials. Launched the mobile website “e-chiken Mobile” for healthy volunteer trial information.
August: Began recruiting patients for disease-specific trials, health food studies, and cosmetic trials. Launched the PC-based trial information site “U”
June: “e-Clinical Trial Mobile” was renewed and renamed to “Seikatsu Kojo Mobile”. Reorganized as Clinical Trial Co., Ltd. (a corporation).
March: “U” was relaunched as “Seikatsu Kojo WEB”.
March: Established CROèe Co., Ltd., a CRO specializing in patient recruitment.
June: Clinical Trial Co., Ltd. obtained Privacy Mark certification and ISO/IEC 27001:2005, JIS Q 27001:2006.
CROèe joined the clinical development support network cooperative “SMONA”.
March: Clinical Trial Co., Ltd. opened the Osaka office and partnered with the clinical trial specialty clinic “Tokyo Center Clinic”.
February: Opened the Fukuoka office.
March: Established SMO CTS Co., Ltd.
July: CROèe obtained ISO/IEC 27001 certification. Established U.S. subsidiary CROèe US INC.
February: Established Asia’s first patient recruitment network “APRO”.
March: Launched Japan’s first clinical trial search app “Seikatsu Kojo App” (Android & iOS).
May: Opened the oncology-focused web portal “Oncolo”.
January: “Seikatsu Kojo WEB” began information collaboration with Yahoo! Healthcare.
April: Launched rental service for trial-use mobile device “cPhone”, pediatric trial support app, and “Patient Insight Pack” for patient research service.
July: Built strategic collaboration with EPS Co., Ltd. for subject recruitment.
August: Began offering white papers summarizing subject recruitment information.
September: Launched “Orphan Disease Recruitment Quick Package” specialized in rare diseases.
October: “Oncolo” formed collaboration with “INTELLIM” in oncology.
December: “Oncolo” and “AstraZeneca” conducted a study on retesting in lung cancer patients.
September: “Oncolo” and National Cancer Center Hospital launched Japan’s first ongoing rare cancer seminar “Meet the Expert”.
Held charity concert “Oncolo Presents: Remember Girls Power Vol.2”.
October: Launched rare disease information site “RareS.”.
January: “Oncolo” and West Japan Oncology Group started the ongoing seminar “Osaka Oncology Seminar”.
Launched senior health community club “Seikatsu Kojo Club”.
March: Launched a new communication channel for patients via “Pharmacy Network”.
May: Launched the cancer consultation service “Oncole”.
September: Held charity concert “Oncolo Presents: Remember Girls Power Vol.3”.
October: Launched “Connect Health”, a site delivering health tech news globally.
November: CROèe, University of Tokyo, and Neopharma Japan launched “IT Healthcare” joint program. Established “3H Life Science Institute” for research connecting people and health.
February: “RareS.” co-hosted the official Rare Disease Day event “RDD University of Tokyo” with the University of Tokyo.
March: Oncolo and certified NPO “Kibou no Kai” began stomach cancer caravan 2019.
April: Transitioned to a holding company structure with 3H Holdings.
May: 3H Holdings and University of Tokyo launched “Patient-Centric Rare Disease R&D Program”.
August: 3H Clinical Trial opened a new center in Miyazaki.
September: Oncolo held charity concert “Remember Girl’s Power!! 2019”.
November: 3H Medi Solution and A2 Healthcare formed a partnership to promote patient engagement in drug development.
February: RareS. supported the official Rare Disease Day event “RDD University of Tokyo Pharmacy” with the University of Tokyo.
April: Launched “3H P-Guardian”, an ePRO system designed with a patient- and researcher-first approach.
May: “Oncolo” began collaboration with “Evaluate” for information sharing.
July: Launched hybrid-style virtual clinical research.
July: Published an educational website for children on COVID-19, in collaboration with the University of Tokyo’s IT Healthcare Program.
September: Held “Remember Girl’s Power!! 2020” charity concert online.
September: Started developing a follow-up system for gene therapy patients with the National Center for Child Health and Development.
October: Launched a video series “All About Stomach Cancer” in collaboration with the Japanese Gastric Cancer Association and certified NPO “Kibou no Kai”.
January: Established joint venture “Four H” with HYPER CUBE.
March: “Oncolo” published a book titled “A Guide to Optimal Cancer Treatment for You”.
September: Held “Remember Girl’s Power!! 2021” charity concert online.
October: Partnered with Science 37® to enable Decentralized Clinical Trials (DCT) in Japan and enhance patient enrollment.
February: Joined the M3 Group
© 2025 · Your Website. Theme by HB-Themes.